Skip to main content
Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · IEX Real-Time Price · USD
6.89
+0.07 (1.03%)
At close: Jul 19, 2024, 4:00 PM
6.99
+0.10 (1.45%)
Pre-market: Jul 22, 2024, 7:44 AM EDT

Verve Therapeutics Revenue

Verve Therapeutics had revenue of $16.05M in the twelve months ending March 31, 2024, with 379.79% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.70M with 305.63% year-over-year growth. In the year 2023, Verve Therapeutics had annual revenue of $11.76M with 505.77% growth.

Revenue (ttm)
$16.05M
Revenue Growth
+379.79%
P/S Ratio
36.05
Revenue / Employee
$62,937
Employees
255
Market Cap
578.52M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202311.76M9.82M505.77%
Dec 31, 20221.94M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Emergent BioSolutions 1.19B
Varex Imaging 855.80M
Orthofix Medical 760.05M
Pharming Group 280.83M
Alector 96.41M
IRadimed 67.69M
Allogene Therapeutics 65.00K
Revenue Rankings

VERV News

More News